Company Overview and News

India’s automobile industry sees rural India driving sales in 2018-19

2018-04-10 livemint
Mumbai/New Delhi: India’s top automobile manufacturers are expecting robust rural sales in the current fiscal year as a favourable monsoon and faster economic growth are likely to boost farm income.
Upvote Downvote

Auto weekly wrap: Motherson gobbles up another component maker, inches closer to Maruti in revenues

2018-04-07 moneycontrol
Did you know the revenue of Noida-based auto component maker Motherson Sumi Systems is nearly as big as that of homegrown two-wheeler heavyweights Hero MotoCorp and Bajaj Auto put together?
Upvote Downvote

Tokyo stocks drop marginally in thin trading

Stocks ended marginally lower Monday, the first trading day of fiscal 2018, as they lacked a clear direction due to a dearth of fresh incentives.
Upvote Downvote

Toyota, Suzuki to sell each others’ models in India

New Delhi : Japanese auto majors Toyota Motor Corporation and Suzuki Motor Corporation on Thursday said they have agreed to sell hybrid and other vehicles to each other for the Indian market.
Upvote Downvote

Toyota, Suzuki Agree to Sell Each Other's Vehicles in India - Bloomberg

2018-03-30 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Toyota-Suzuki alliance deepens as both agree to sell each other’s vehicles in India

Toyota Motor Corp. and Suzuki Motor Corp. agreed to sell each other’s hybrid cars and other vehicles in India, deepening an alliance between the automakers.
Upvote Downvote

News Live: RBI imposes Rs 589m penalty on ICICI Bank

2018-03-29 moneycontrol
ICICI Bank board gives clean chit to Chanda Kochhar, says not the lead banker to Videocon Group
Upvote Downvote

Toyota, Suzuki to supply each other cars in India: report

2018-03-29 livemint
Toyota Motor Corp. will mutually supply cars in India with Suzuki Motor Corp. starting in 2019, a move that would expand the Japanese company’s foothold in emerging markets, the Nikkei reported on Wednesday.
Upvote Downvote

Nissan to re-enter Pakistan market by producing Datsuns with local manufacturer

YOKOHAMA – Nissan Motor Co. said Wednesday it will re-enter the Pakistan market in 2020 with a local production of its low-cost Datsun brand vehicles under a tie-up with a local partner.
Upvote Downvote

How 2 disruptions are reshaping India’s automobile industry

2018-03-23 livemint
New Delhi: For India’s top carmakers, it’s the best of times and the worst of times.
Upvote Downvote

Japan offers $940 million to boost nation's space startups

2018-03-20 cnbc
Japan is offering $940 million to fund space start-ups in a new push to grow the industry, the government announced Tuesday at an event in Tokyo.
Upvote Downvote

Suzuki launches Intruder variant at Rs 1,06,896

2018-03-16 thehindubusinessline
Suzuki Motorcycle India today launched an advanced version of its bike Intruder with a fuel injection option in a bid to tighten its hold further in the cruiser segment.
Upvote Downvote

Gujarat auto firms face supply crunch amid rising demand

2018-03-16 moneycontrol
Auto firms in Gujarat are facing a shortage in the auto parts supply due to the limited number of vendors after several car makers rushed to Gujarat to set up manufacturing plants, according to a report in Mint.
Upvote Downvote

India overtakes UK in automotive sales to emerge as fifth largest in the world

2018-03-15 moneycontrol
India’s automotive sales surged the second fastest in the world in 2017, with total numbers trumping developed markets like UK and France and coming within striking distance of Germany.
Upvote Downvote

News Live: Feb trade deficit at $12bn; Except for PNB, no unauthorised LoUs issued by PSBs, says SBI;

2018-03-15 moneycontrol
PNB scam exclusive: Banks' credit limit exposure to Nirav Modi pegged at Rs 321cr in FIR, may actually be Rs 3,000cr
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...